Belmont Global Advisors’s Theriva Biologics TOVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
Sell
-40
Closed -$801K 73
2015
Q4
$801K Sell
40
-23
-37% -$461K 1.04% 22
2015
Q3
$1.25M Buy
+63
New +$1.25M 2.12% 10
2015
Q2
Sell
-6
Closed -$109K 116
2015
Q1
$109K Buy
+6
New +$109K 0.11% 78
2014
Q3
Sell
-3
Closed -$43K 137
2014
Q2
$43K Sell
3
-8
-73% -$115K 0.03% 125
2014
Q1
$257K Sell
11
-132
-92% -$3.08M 0.22% 100
2013
Q4
$1.92M Buy
+143
New +$1.92M 1.55% 16